Barinthus Bio Announces Strategic Pipeline Prioritization Fo

The development of VTP-300 in chronic Hepatitis B (CHB) and VTP-1000 in celiac disease will be prioritized.The pipeline prioritization is expected to result in a reduction in workforce of approximately

Related Keywords

United Kingdom , Gaza , Israel General , Israel , Ukraine , Barinthus Bio , Audra Friis , Jonothan Blackbourn , Kevin Gardner , Barinthus Biotherapeutics , Christopherm Calabrese , Exchange Commission , Sam Brown Inc , Congress On , Nasdaq , European Association , Chief Executive Officer , United European Gastroenterol , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Current Reports ,